Alpha and beta adrenergic blockade in hypertension.
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000328:Adult; D001794:Blood Pressure; D001835:Body Weight; D002986:Clinical Trials as Topic; D004336:Drug Antagonism; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007024:Hypotension, Orthostatic / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010643:Phenoxybenzamine / Q000008:administration & dosage* / Q000009:adverse effects; D005082:Physical Exertion; D010919:Placebos; D011187:Posture; D011433:Propranolol / Q000008:administration & dosage* / Q000009:adverse effects; D011674:Pulse
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004338:Drug Combinations; D010919:Placebos; D010643:Phenoxybenzamine; D011433:Propranolol